{
    "nctId": "NCT03718455",
    "briefTitle": "Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes",
    "officialTitle": "Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes in Women With Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 1,
    "primaryOutcomeMeasure": "Evaluate if Magseed is a Viable Alternative to Radioactive Seed as a Localization Method for Biopsy Proven Metastatic Breast Carcinoma Following Neoadjuvant Chemotherapy.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women 18 years or older\n2. Neoadjuvant chemotherapy planned prior to surgical excision\n3. Scheduled for target axillary lymph node dissection including the localized lymph node and sentinel lymph node\n\nExclusion Criteria:\n\n1. Pregnant or nursing women\n2. Allergy to lidocaine or gadolinium\n3. Contraindication to MRI (i.e. pacemaker)\n4. Axillary Infection\n5. Prior axillary radiation\n6. Known allergy to bone wax, beeswax or propolis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}